首页> 外文OA文献 >PARP Inhibitor Olaparib Use in a BRCA1-Positive Patient With Metastatic Triple-Negative Breast Cancer, Without the Initial Use of Platinum-Based Chemotherapy, Showing Significant Rapid Near Resolution of Large Liver Metastasis While Patient Experienced Gout-Like Symptoms

【2h】

PARP Inhibitor Olaparib Use in a BRCA1-Positive Patient With Metastatic Triple-Negative Breast Cancer, Without the Initial Use of Platinum-Based Chemotherapy, Showing Significant Rapid Near Resolution of Large Liver Metastasis While Patient Experienced Gout-Like Symptoms

机译：PARP抑制剂Olaparib在BRCA1阳性患者中使用转移性三阴性乳腺癌，而不初始使用铂类化疗，显示出大型肝脏转移的显着快速分辨，而患者经历过痛风的症状

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Trevanne Matthews Hew; Lara Zuberi;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancer [J] . Rebecca A Dent, Geoffrey J Lindeman, Mark Clemons, Breast Cancer Research . 2013,第5期

机译：口服PARP抑制剂奥拉帕尼联合紫杉醇用于转移性三阴性乳腺癌患者的一线或二线治疗的第一阶段试验
2. Heterogeneity of targeted lung lesion predicts platinum-based first-line therapy outcomes and overall survival for metastatic triple-negative breast cancer patients with lung metastasis: a “PET biopsy” method [J] . Yizhao Xie, Bingxin Gu, Xichun Hu, Cancer Management and Research . 2019,第2期

机译：靶向肺病变的异质性可预测以铂为基础的一线治疗结果和转移性三阴性乳腺癌伴肺转移的患者的总生存期：一种“ PET活检”方法
3. Impressive Response to Concomitant Platinum-based Chemotherapy and Yttrium-90 in a Patient with Heavily Pretreated Triple-negative Breast Cancer Widely Metastasized to the Liver [J] . Aurelio Castrellon, Steven M. Nguyen, Federico Bengoa, Cureus. . 2017,第6期

机译：对大量转移至肝脏的高度预处理的三阴性乳腺癌患者，伴随铂类化学疗法和Yttrium-90的治疗反应令人印象深刻
4. Correlations between depressive symptoms and quality of life in metastatic breast cancer patients during chemotherapy [C] . Dragomir B.I., Campean A. European Association of Psychosomatic Medicine., Annual Meeting. . 2014

机译：化疗期间转移性乳腺癌患者抑郁症状与生活质量的相关性
5. Symptoms, symptom distress, depressive symptoms, and uncertainty in newly diagnosed head and neck cancer patients receiving definitive radiotherapy with or without chemotherapy [D] . Haisfield-Wolfe, Mary Ellen 2009

机译：新诊断头颈癌患者接受明确放疗并伴或不伴化疗的症状，症状困扰，抑郁症状和不确定性
6. PARP Inhibitor Olaparib Use in a BRCA1-Positive Patient WithMetastatic Triple-Negative Breast Cancer Without the Initial Use ofPlatinum-Based Chemotherapy Showing Significant Rapid Near Resolution of LargeLiver Metastasis While Patient Experienced Gout-Like Symptoms [O] . Trevanne Matthews Hew, Lara Zuberi -1

机译：PARP抑制剂Olaparib在BRCA1阳性患者中的应用转移性三阴性乳腺癌无需最初使用基于铂的化学疗法显示出大的快速近分辨率患者经历痛风样症状时发生肝转移
7. Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancer [O] . Dent, Rebecca A, Lindeman, Geoffrey J, Clemons, Mark, 2015

机译：口服PARP抑制剂奥拉帕尼联合紫杉醇用于转移性三阴性乳腺癌患者的一线或二线治疗的I期试验

PARP Inhibitor Olaparib Use in a BRCA1-Positive Patient With Metastatic Triple-Negative Breast Cancer, Without the Initial Use of Platinum-Based Chemotherapy, Showing Significant Rapid Near Resolution of Large Liver Metastasis While Patient Experienced Gout-Like Symptoms

著录项

引文网络

相似文献

相关主题

期刊订阅